Maxime Beretta

628 total citations
8 papers, 97 citations indexed

About

Maxime Beretta is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Maxime Beretta has authored 8 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 4 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Maxime Beretta's work include HIV Research and Treatment (5 papers), Hepatitis B Virus Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Maxime Beretta is often cited by papers focused on HIV Research and Treatment (5 papers), Hepatitis B Virus Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Maxime Beretta collaborates with scholars based in France, Switzerland and United Kingdom. Maxime Beretta's co-authors include Hugo Mouquet, Martine Braibant, Alain Moreau, James P. Di Santo, Oriane Fiquet, Malika Ait‐Goughoulte, Stanislas Pol, Nadège Pelletier, Marie‐Laure Chaix and Valérie Lorin and has published in prestigious journals such as The Journal of Experimental Medicine, Hepatology and Journal of Virology.

In The Last Decade

Maxime Beretta

8 papers receiving 97 citations

Peers

Maxime Beretta

EPIDE

HEPAT

ID

IMMUN

VIROL

Manuela Pogliaghi Italy

Timothy G. Wanninger United States

Manon Nayrac Canada

Ahmad Hosseinzadeh Adli Iran

Sebastiaan Hullegie Netherlands

Hyojin Lee South Korea

Daniel Kvistad United States

L Ratcliffe United Kingdom

Janusz J Stańczak Poland

Gurpreet Brar United States

Manuela Pogliaghi Italy

Maxime Beretta

48 ×0.7

EPIDE

36 ×0.9

HEPAT

37 ×1.2

ID

19 ×0.6

IMMUN

52 ×2.1

VIROL

Citations per year, relative to Maxime Beretta Maxime Beretta (= 1×) peers Manuela Pogliaghi

Countries citing papers authored by Maxime Beretta

Since Specialization

Citations

This map shows the geographic impact of Maxime Beretta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Beretta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Beretta more than expected).

Fields of papers citing papers by Maxime Beretta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Beretta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Beretta. The network helps show where Maxime Beretta may publish in the future.

Co-authorship network of co-authors of Maxime Beretta

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Beretta. A scholar is included among the top collaborators of Maxime Beretta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Beretta. Maxime Beretta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Beretta, Maxime, Cyril Planchais, Pierre Rosenbaum, et al.. (2024). Enhanced hepatitis B virus–specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection. Hepatology. 82(2). 470–486. 1 indexed citations

2.

Beretta, Maxime & Hugo Mouquet. (2022). Advances in human monoclonal antibody therapy for HBV infection. Current Opinion in Virology. 53. 101205–101205. 19 indexed citations

3.

Beretta, Maxime, Maryline Bourgine, Malika Ait‐Goughoulte, et al.. (2020). Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers. The Journal of Experimental Medicine. 217(10). 44 indexed citations

4.

Beretta, Maxime, Alain Moreau, Asma Essat, et al.. (2020). Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain. Scientific Reports. 10(1). 16744–16744. 3 indexed citations

5.

Moreau, Alain, et al.. (2020). Escape of HIV-1 Envelope Glycoprotein from Restriction of Infection by IFITM3. Journal of Virology. 95(5). 11 indexed citations

6.

Beretta, Maxime & Hugo Mouquet. (2019). Ingénierie de lymphocytes B humains produisant des anticorps neutralisant le virus VIH-1 par édition génique CRISPR-Cas9. médecine/sciences. 35(12). 993–996. 2 indexed citations

7.

Beretta, Maxime, Alain Moreau, Asma Essat, et al.. (2018). Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains. AIDS. 32(14). 1917–1926. 8 indexed citations

8.

Beretta, Maxime, Alain Moreau, Asma Essat, et al.. (2018). Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic. Journal of Virology. 93(6). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact